RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 21 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 6,126,482 | $3,002,000 | 0.16% |
Bison Wealth, LLC | 25,710 | $13,000 | 0.01% |
Virtu KCG Holdings LLC | 99,203 | $49,000 | 0.00% |
Renaissance Technologies | 507,000 | $248,000 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 1,136 | $557,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 6,000 | $3,000 | 0.00% |
JANE STREET GROUP, LLC | 10,493 | $5,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,005 | $0 | 0.00% |
NORTHERN TRUST CORP | 12,782 | $6,000 | 0.00% |
Brookstone Capital Management | 9 | $0 | 0.00% |